Skip to content

Convergent Life Sciences, Inc.

Country not established

Devices
1

What Convergent Life Sciences, Inc. makes

Convergent Life Sciences, Inc. manufactures the TARGET3D FUSION, a medical imaging system designed for targeted radiation therapy planning and treatment guidance, integrating 3D imaging and real-time tracking capabilities.

The TARGET3D FUSION is classified as a Class II device under FDA regulations and is listed in the FDA’s 510(k) clearance registry. The company is based in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • TARGET3D Fusion Ref K140033

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does Convergent Life Sciences, Inc. have in the registry?

The registry currently lists 1 device for Convergent Life Sciences, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Convergent Life Sciences, Inc.'s devices?

Among its 1 most recently registered device, Convergent Life Sciences, Inc. has devices listed in FDA 510(k) (1 device).

What risk classes do Convergent Life Sciences, Inc.'s devices fall under?

Among its 1 most recently registered device, the classes recorded for Convergent Life Sciences, Inc.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Convergent Life Sciences, Inc. in the registry?

The most recently registered devices listed for Convergent Life Sciences, Inc. include TARGET3D FUSION.

Generated automatically from registry data and not verified by a human reviewer.